Both Private and Public Sectors along with Academia Come Together at the 2013 BIO International Convention

  • Contact: Abigail Hirsch
  • Phone: 202-962-9235
  • Email: ahirsch@bio.org
  • Recommend
  • Tweet
  • Print
  • Email

Washington, DC (March 14, 2013) –Universities have historically been on the front lines of translating innovative research into novel medicines and technologies useful to patients. With that in mind, the 2013 BIO International Convention will look to highlight the role of academia in the advancement of the biotechnology field through the BIO Alliance Zone and the Translational Research Forum.Hosted by the Biotechnology Industry Organization (BIO), the Convention, celebrating its 20thanniversary, will take place April 22-25, 2013 at McCormick Place in Chicago, Ill.

“With 70% of academic and research institutions at Convention participating in partnering, the BIO Alliance Zone, Translational Research Forum and programs focused on the link between academia, industry representatives and investors is invaluable,” said BIO President and CEO, Jim Greenwood.

The BIO Alliance Pavilion: Academic Zone is dedicated to academic and research institutions and serves as a pavilion for academic and industry partnering meetings as well as provides a venue for highlighting the involvement of academia in the Convention and the industry as a whole. The Academic Zone will allow companies to discover new funding mechanisms, energize pipeline and drug development opportunities, and connect with innovative academic stakeholders.

A special program dedicated to exploring ways that the private sector, academia and the public sector, in both emerging and developed markets, can leverage existing mechanisms and pursue partnerships to help make innovative products available, The Translational Research Forum: Moving from Translational to Transformational, will survey best practices and outcomes from partnerships in transformational research and explores with the audience ways to leverage a greater return on public investment.

Sponsored by Northwestern, the University of Chicago, the University of Illinois and the University of Virginia, Innovation, the Forum will take place Monday, April 22nd, 1:30 – 6:30 p.m. in Building N426 C.

The opening address will be delivered by W. Mark Crowell, Executive Director, UVa Innovation, Associate Vice President, Research, University of Virginia, 2013 AUTM Bayh-Doyle Award Recipient.

Translational Research Forum panel discussions include:

Funding Models for Translational Research

Moderator: Norbert Riedel, PhD, Corporate Vice President, Chief Science and Innovation Officer, Baxter International Inc

Speakers: Karen Bernstein, PhD, Chairman & Editor-in-Chief, BioCentury Publications, Edward Lanphier, President and Chief Executive Officer, Sangamo BioSciences, Inc., Chad A. Mirkin, Director, International Institute of Nanotechnology, George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science & Engineering, and Professor of Medicine, Northwestern University, Founder of AuraSense, AuraSense Therapeutics, Nanospher and NanoInk, and Daniel Perez, MD, Partner, Bay City Capital

Academia, Industry and Government: New Collaborative Approaches

Moderator: Vicki L. Loise, CMP, CAE, Executive Director, Association of University Technology Managers

Speakers: Dr. Ruxandra Draghia-Akli, MD, PhD, Director, Health Directorate, Research and Innovation DG, European Commission, Reid J. Leonard, Managing Director, Merck Research Venture Fund , Rajesh Ranganathan, PhD, Associate Director, Translational Research, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)

Accelerators: Leveraging Regional Resources for Growth

Moderator: Abigail Barrow, PhD, Director, Massachusetts Technology Transfer Center

Speakers: Richard Bendis , President & Chief Executive Officer, BioHealth Innovation, Inc., Aaron Miscenich, President, New Orleans BioInnovation Center, Kathleen Rousche, PhD, Program Director, NCAI, National, Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) and Duane Roth, Chief Executive Officer, CONNECT

To learn more about the BIO Alliance Zone, Translational Research Forum and the various universities and academic attendees, please visit http://convention.bio.org/academic.

Now open, the BIO International Convention also features the industry's largest partnering event, hosting a record breaking 25,000+partnering meetings in 2012.  More than 4,000 companies participated in One-on-One Partnering meetings in the BIO Business Forum™ and in the BIO Exhibition. These efficient meetings foster the opportunity for companies to initiate business contacts in a friendly environment and schedule meetings prior to the Convention.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.

 

Upcoming BIO Events 

March 25-27, 2013
San Diego, CA
 
April 22 – 25, 2013
Chicago, IL
 
June 16-19, 2013
Montreal, Canada

 

 

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.